Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 3 September 2009, Vol. 114, No. 10, pp. 2172-2180.
Prepublished online as a Blood First Edition Paper on July 8, 2009; DOI 10.1182/blood-2008-11-191536.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2008-11-191536v1
114/10/2172    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Jack, G. D.
Right arrow Articles by Friedman, A. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jack, G. D.
Right arrow Articles by Friedman, A. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted November 24, 2008
Accepted June 28, 2009

M-CSF elevates c-Fos and phospho-C/EBP{alpha}(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification

Graham D. Jack, Li Zhang, and Alan D. Friedman*

Division of Pediatric Oncology, Johns Hopkins University, Baltimore, MD, United States

* Corresponding author; email: afriedm2{at}jhmi.edu.

The role of hematopoietic cytokines in lineage commitment remains uncertain. To gain insight into the contribution of cytokine signaling to myeloid lineage specification, we compared G-CSF and M-CSF signaling in Ba/F3 cells expressing both the G-CSF and M-CSF receptors and in lineage-negative murine marrow cells. G-CSF and M-CSF serve as proto-types for additional cytokines that also influence immature myeloid cells. G-CSF specifically activated STAT3 and induced SHP2 phosphorylation, whereas M-CSF preferentially activated PLC{gamma}2 and thereby ERK to stabilize c-Fos and stimulate C/EBP{alpha}(S21) phosphorylation. In contrast, activation of Jun kinase or c-Jun was similar in response to either cytokine. Inhibition of ERK prevented induction of c-Fos by M-CSF and reduced C/EBP{alpha} phosphorylation and formation of CFU-M. SHP2 inhibition reduced ERK activation in G-CSF but not M-CSF and reduced CFU-G, underscoring divergent pathways to ERK activation. Phorbol ester mimicked the effect of M-CSF, activating ERK independent of SHP2. In summary, M-CSF activates ERK more potently than G-CSF and thereby induces higher levels of c-Fos and phospho-C/EBP{alpha}(S21), which may directly interact to favor monopoiesis, whereas G-CSF activates STAT3 and SHP2, potentially shifting the balance to granulopoiesis via gene induction by C/EBP{alpha} homodimers and via effects of SHP2 on regulators besides ERK.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020